Saturday, September 18, 2021

Location
Crowne Plaza Time Square Manhattan
1605 Broadway
New York, NY 10019
Phone: 212-977-4000

The ever-increasing presence of cardiometabolic risk factors continues to be a major challenge for health care providers in the United States. Current estimates suggest approximately 23%-38% of all US adults have metabolic syndrome, a constellation of cardiometabolic risk factors that includes excessive abdominal fat, insulin resistance, dyslipidemia, and hypertension. These risk factors converge with chronic inflammation, hypercoagulation, and certain genetic traits to the detriment of patient health. Patients with metabolic syndrome have 3 to 5 times the likelihood of developing diabetes, and at least double the risk of cardiovascular disease (CVD) and stroke. Other CVD consequences, such as acute coronary syndrome (ACS), thrombosis, and atrial fibrillation, have also been linked to metabolic syndrome. In addition, patients with multiple cardiometabolic risk factors commonly suffer comorbidities that can exacerbate CVD risk and negatively affect quality of life.

The 5th Annual New York Cardio-Endo-Renal Collaborative (NY CERC) will focus on strategic and novel approaches to the management of integrated cardiometabolic diseases. The expert faculty will deliver state-of-the-art clinical updates and strategies aimed at the intersection of metabolic disease and CVD prevention. Join us to hear expert perspectives on managing patients with cardiometabolic risk factors. Given the prevalence of cardiometabolic diseases and the scope of the problem, there is great need to bring scientific breakthroughs and clinical updates to a multidisciplinary mix of specialty clinicians.

At Physicians' Education Resource®, LLC (PER®), our top priority is ensuring the safety and security of our attendees, faculty, exhibitors, staff, and operational personnel. We are dedicated to remaining informed about the ongoing COVID-19 pandemic at the global and local levels. As we develop the programming for this activity, PER® is working diligently to implement health and safety protocols based on the advice of health experts and the latest guidelines and local regulations to mitigate the risk of exposure to COVID-19 and to optimize health and safety conditions for attendees during the event. Ongoing updates on PER®'s plans related to this event, including education and programming, will continue to be available at https://www.gotoper.com/conferences/cerc/meetings/5th-annual-cardio-endo-renal-collaborative. Please note attendance at any public event increases the risk of contracting COVID-19 or other airborne illness, and attendees assume all risk associated with attendance. Any attendees who feel ill, regardless of their symptoms, should not attend this event.

• Gain insights into the importance of screening and early detection of cardiometabolic risk factors to prevent irreversible cardiovascular damage
• Improve competence in the integration of novel and newly approved therapies in the management of cardiovascular, renal, and metabolic diseases
• Learn strategies for overcoming barriers to the multidisciplinary care of patients with cardiac, endocrine, and renal disease
• Determine optimal treatment algorithms for specific patient groups
• Hear how leading experts and your peers are managing treatment for their patients with cardiac, renal, and metabolic diseases

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource^®, LLC is approved by the California Board of Registered Nursing, Provider #16669.

This educational activity is directed toward cardiologists, endocrinologists, specialty nurse practitioners, specialty physician assistants, certified diabetes educators, other specialty allied health professionals, nephrologists, primary care providers and other health care professionals who treat patients with any aspects of cardiometabolic syndrome.

Upon successful completion of this educational activity, you should be better prepared to:

• Analyze clinical strategies for evaluation and diagnosis of patients presenting with cardiac, endocrine, and renal disease
• Evaluate the potential clinical impact of recent clinical trial data on management of cardiac, endocrine, and renal disease
• Identify current strategies and recent advances in the prevention of cardiometabolic disorders
• Employ strategies for patient counseling to improve education, preventive practices, adherence, and self-management

• Primary and secondary prevention of cardiovascular disease
• Beyond statins: other low-density lipoprotein cholesterol–lowering treatments
• Advances in heart failure management
• Related thyroid conditions
• Prevention of osteoporosis
• Cardiometabolic risk reduction in comorbid conditions